Form 4: Oracle Corp: CFO Maxson Reports Stock Option and RSU Grants
Statement of Changes in Beneficial Ownership
Hilary B. Maxson, Chief Financial Officer of Oracle Corp, reported the acquisition of stock options and restricted stock units on May 5, 2026, with vesting schedules extending through 2030.
Summary
- Hilary B. Maxson, Chief Financial Officer of Oracle Corp (ORCL), has reported transactions related to equity compensation.
- On May 5, 2026, Maxson was granted stock options for 224,441 shares with an exercise price of $185.35.
- These stock options have a vesting schedule: 40% on May 5, 2027, 30% on May 5, 2028, 20% on May 5, 2029, and 10% on May 5, 2030, contingent upon continued employment.
- Additionally, Maxson was granted 56,111 restricted stock units (RSUs) on the same date.
- The RSUs also have a staggered vesting schedule identical to the stock options, with full vesting by May 5, 2030, subject to continued employment.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it represents routine equity compensation for a key executive rather than a significant financial event or strategic shift.
Positives
- Grant of stock options and RSUs indicates management's continued incentive and alignment with the company's performance.
- The vesting schedule over several years encourages long-term commitment from the Chief Financial Officer.
Risks
- The value of stock options and RSUs is subject to market fluctuations and the company's future stock performance.
- Vesting is contingent on continued employment, meaning any departure before vesting dates would result in forfeiture of unvested awards.
Future Outlook
The future outlook for the granted stock options and RSUs is tied to Oracle Corp's stock performance and the continued employment of Hilary B. Maxson through the respective vesting dates up to May 5, 2030.
Industry Context
StockSavvy.ai notes that the granting of stock options and RSUs to key executives like the CFO is a standard practice in the technology sector, including enterprise software companies like Oracle, to incentivize performance and retain talent.
Stakeholder Impact
- Shareholders: The grants do not immediately impact share count but represent potential future dilution if options are exercised and RSUs are settled. The alignment of executive incentives with company performance can be viewed positively.
- Employees: This filing is specific to the CFO and does not directly impact other employees, though it reflects standard compensation practices.
- Management: The CFO's compensation is directly tied to the company's stock performance and continued tenure.
Next Steps
- Continued employment through May 5, 2027, for the first 40% vesting of options and RSUs.
- Continued employment through subsequent vesting dates up to May 5, 2030, for the remaining portions of the awards.
Key Dates
| Date | Description |
|---|---|
| 05/05/2026 | Earliest transaction date; date of stock option grant and RSU grant. |
| 05/05/2027 | First vesting date for 40% of stock options and RSUs. |
| 05/05/2028 | Second vesting date for 30% of stock options and RSUs. |
| 05/05/2029 | Third vesting date for 20% of stock options and RSUs. |
| 05/05/2030 | Final vesting date for 10% of stock options and RSUs. |
| 05/07/2026 | Date the Form 4 was signed. |
Keywords
Oracle Corp, ORCL, Form 4, Stock Options, Restricted Stock Units, RSU, Equity Compensation, Insider Trading, Beneficial Ownership, Hilary B. Maxson, Chief Financial Officer, Vesting Schedule
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.